Sally C. Pipes
Commentary
Misguided Govt Policies Mean Employer-Based Coverage Costs Soar
The cost of employer-based health insurance continues to reach new heights. According to a report out this month from the Kaiser Family Foundation, premiums for a family health plan have risen 47% since 2011, and during that same period, employee earnings rose by 31%, while overall inflation ticked up just 19%. What’s ...
Sally C. Pipes
November 18, 2021
Commentary
Federal government misses opportunity with unlawful private sector vaccine mandates
Earlier this month, the Biden administration mandated that employees at businesses with more than 100 workers be vaccinated or undergo weekly COVID-19 testing starting at the beginning of next year. Just two days later, the U.S. Court of Appeals for the 5th Circuit halted the order in response to a ...
Sally C. Pipes
November 15, 2021
Commentary
U.S. Bureaucrats Are An Impediment To Pandemic Recovery
Late last month, the Biden administration announced a new initiative to lower the cost of at-home Covid-19 tests and make them more widely available. It’s long past time. Throughout the pandemic, bureaucratic sclerosis has proven the American regulatory apparatus to be an impediment to fighting Covid-19—not to mention future public health threats. ...
Sally C. Pipes
November 8, 2021
Commentary
Democrats Abandon US Patients to Rescue Drug-Pricing Reform
Just a few days ago, it appeared that Democrats had given up on including prescription drug pricing reforms in their massive spending bill. But not anymore. In an eleventh-hour turn of events, congressional Democrats this week resurrected their long-standing desire to levy government price controls on prescription drugs. If lawmakers successfully deploy their latest ...
Sally C. Pipes
November 4, 2021
Commentary
Biden’s new plan isn’t any better for your health
Last week, President Joe Biden unveiled a new social spending framework that omitted many of the healthcare provisions Democrats have been calling for. One provision that has survived is a massive and wasteful expansion of Obamacare . In March, Congress made federal tax credits available to those shopping for coverage on the exchanges with ...
Sally C. Pipes
November 1, 2021
Commentary
Single-Payer Will Worsen Healthcare Workers’ Plight
Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what’s been called “Striketober,” frontline staff are walking out of hospitals, emergency rooms, and doctor’s offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted to authorize a strike over ...
Sally C. Pipes
October 25, 2021
Commentary
Sally Pipes: Democrats’ Drug Pricing Reforms Aren’t What They Seem
As part of their spending bill, Congressional Democrats are advancing legislation that’ll empower Medicare to “negotiate” drug prices in the program’s Part B and Part D benefits. They insist this policy enjoys broad support among voters. But they’re misleading the public. What Democrats are proposing is in fact a sweeping ...
Sally C. Pipes
October 19, 2021
Drug Pricing
NEW BRIEF: Focus Groups Overwhelmingly Disapprove of Government “Negotiated” Drug Pricing
Today, the Pacific Research Institute published an issue brief revealing overwhelming public disapproval for Medicare reforms that Congress is considering as part of its $3.5 trillion spending bill. Click here to read the full issue brief, “Drug Pricing Proposals Threaten America’s Most Vulnerable Patients.” “It’s a relief that Americans oppose ...
Sally C. Pipes
October 19, 2021
Commentary
Democrats Have Built a Healthcare Agenda Around an Imaginary Crisis
Is America in the midst of a health insurance crisis? That’s the picture Democrats in Washington are painting. According to their narrative, health coverage is out of reach for a number of Americans. Only an aggressive — and exorbitantly expensive — effort to expand the number of people covered by taxpayer-funded insurance ...
Sally C. Pipes
October 15, 2021
Commentary
Mixed Messaging On Boosters Leaves Americans Dazed And Confused
The Food and Drug Administration recently revised its emergency use authorization for Pfizer-BioNTech’s COVID-19 vaccine by approving a booster shot for individuals 65 and older, immunocompromised adults, and people with a high risk of exposure to the virus at work. It’s an exciting development for the nearly 80% of vaccinated Americans who want a ...
Sally C. Pipes
October 11, 2021
Misguided Govt Policies Mean Employer-Based Coverage Costs Soar
The cost of employer-based health insurance continues to reach new heights. According to a report out this month from the Kaiser Family Foundation, premiums for a family health plan have risen 47% since 2011, and during that same period, employee earnings rose by 31%, while overall inflation ticked up just 19%. What’s ...
Federal government misses opportunity with unlawful private sector vaccine mandates
Earlier this month, the Biden administration mandated that employees at businesses with more than 100 workers be vaccinated or undergo weekly COVID-19 testing starting at the beginning of next year. Just two days later, the U.S. Court of Appeals for the 5th Circuit halted the order in response to a ...
U.S. Bureaucrats Are An Impediment To Pandemic Recovery
Late last month, the Biden administration announced a new initiative to lower the cost of at-home Covid-19 tests and make them more widely available. It’s long past time. Throughout the pandemic, bureaucratic sclerosis has proven the American regulatory apparatus to be an impediment to fighting Covid-19—not to mention future public health threats. ...
Democrats Abandon US Patients to Rescue Drug-Pricing Reform
Just a few days ago, it appeared that Democrats had given up on including prescription drug pricing reforms in their massive spending bill. But not anymore. In an eleventh-hour turn of events, congressional Democrats this week resurrected their long-standing desire to levy government price controls on prescription drugs. If lawmakers successfully deploy their latest ...
Biden’s new plan isn’t any better for your health
Last week, President Joe Biden unveiled a new social spending framework that omitted many of the healthcare provisions Democrats have been calling for. One provision that has survived is a massive and wasteful expansion of Obamacare . In March, Congress made federal tax credits available to those shopping for coverage on the exchanges with ...
Single-Payer Will Worsen Healthcare Workers’ Plight
Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what’s been called “Striketober,” frontline staff are walking out of hospitals, emergency rooms, and doctor’s offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted to authorize a strike over ...
Sally Pipes: Democrats’ Drug Pricing Reforms Aren’t What They Seem
As part of their spending bill, Congressional Democrats are advancing legislation that’ll empower Medicare to “negotiate” drug prices in the program’s Part B and Part D benefits. They insist this policy enjoys broad support among voters. But they’re misleading the public. What Democrats are proposing is in fact a sweeping ...
NEW BRIEF: Focus Groups Overwhelmingly Disapprove of Government “Negotiated” Drug Pricing
Today, the Pacific Research Institute published an issue brief revealing overwhelming public disapproval for Medicare reforms that Congress is considering as part of its $3.5 trillion spending bill. Click here to read the full issue brief, “Drug Pricing Proposals Threaten America’s Most Vulnerable Patients.” “It’s a relief that Americans oppose ...
Democrats Have Built a Healthcare Agenda Around an Imaginary Crisis
Is America in the midst of a health insurance crisis? That’s the picture Democrats in Washington are painting. According to their narrative, health coverage is out of reach for a number of Americans. Only an aggressive — and exorbitantly expensive — effort to expand the number of people covered by taxpayer-funded insurance ...
Mixed Messaging On Boosters Leaves Americans Dazed And Confused
The Food and Drug Administration recently revised its emergency use authorization for Pfizer-BioNTech’s COVID-19 vaccine by approving a booster shot for individuals 65 and older, immunocompromised adults, and people with a high risk of exposure to the virus at work. It’s an exciting development for the nearly 80% of vaccinated Americans who want a ...